Two important questions arising are: (1) does increasing the frequency of MRI detect more active lesions, thus improving the sensitivity of the technique for therapeutic monitoring; (2) do new lesions appearing on monthly long TR scans without showing gadolinium enhancement display enhancement at shorter intervals-evidence that they do would suggest that impairment of the blood-brain barrier is an obligatory early event in the development of lesions in multiple sclerosis. To consider these questions, we have performed weekly MRI for three months in three patients, one with relapsing-remitting and two with secondary progressive multiple sclerosis.
Serial brain MRI at monthly intervals has provided valuable insights into the natural history of multiple sclerosis, and is now often used to monitor the efficacy of experimental treatments. ' 2 Scanning at this interval often shows asymptomatic new lesions in relapsing-remitting or secondary progressive multiple sclerosis, on average five to 10 Thirteen weekly studies were performed with the above protocol on each patient. Lesion activity was reported from hard copies by two radiologists (TH, MG-C). EDSS was 6. Further decline was observed during the study and the final EDSS was 7. Patient 3 (aged 40 years) had secondary progressive multiple sclerosis. The initial EDSS was 7. She had no further decline during the study.
MRI DATA
The weekly gadolinium enhanced scans were reviewed first. During follow up, 38 new enhancing lesions appeared. Thirteen were still enhancing on the final scan. Of these 13, enhancement was present on six scans in one lesion, five scans in two, four scans in three, three scans in one, two scans in three, and the final scan only in three.
Of the 25 new enhancing lesions which could be followed up from the beginning to the end of enhancement, 11 (44%) enhanced for less than one month (on three scans or less). Two lesions enhanced on just one scan (figure).
To compare the sensitivity of weekly and monthly scanning, the first, fifth, ninth, and 13th scans were considered to be the monthly scans for this study. These scans showed 33 new enhancing lesions. Thus monthly scanning would have missed only five of 38 (13%) new enhancing lesions detected on weekly scans (see table: lesions 6, 12, 14, 24, and 25).
The weekly proton density and T2 weighted (long TR) scans were then reviewed without reference to the enhanced images. A total of 16 and the duration of enhancement were not described. 16 As in a previous study of 
